VEGF Trap Abolishes Shear Stress‐ and Overload‐Dependent Angiogenesis in Skeletal Muscle
- 1 September 2006
- journal article
- Published by Wiley in Microcirculation
- Vol. 13 (6), 499-509
- https://doi.org/10.1080/10739680600785717
Abstract
Objective: To determine which elements of the angiogenic process are controlled by VEGF under physiological conditions. Methods: VEGF Trap was administered at 10 mg · kg−1 by subcutaneous injection twice weekly to mice, which were subject to one of two established angiogenic stimuli: ( 1 ) increasing blood flow by administration of prazosin (50 mg L−1); ( 2 ) muscle overload by extirpation of a synergist. Angiogenesis was determined by calculating capillary to fiber ratio (C:F), and proliferating cell nuclear antigen (PCNA) staining localized to capillaries or the interstitium used to measure cell proliferation. Characteristic ultrastructural changes were quantified using electron microscopy. Results: Administration of VEGF Trap abolished the increases in C:F seen in both models, and prevented growth of luminal filopodia and large vacuole formation. Overload‐induced proliferation associated with capillaries was reduced, along with endothelial cell number abluminal sprouts and basement membrane breakage. However, interstitial proliferation remained high, along with the increased capillary association of pericytes and fibroblasts. Conclusions: VEGF is required for both models of angiogenesis, although some morphological changes lie upstream, or are independent of, VEGF involvement. The abolition of angiogenesis in a model unaffected by NO inhibition shows that NO is not required for all VEGF‐dependent angiogenesis in vivo.Keywords
This publication has 30 references indexed in Scilit:
- Differential gene and protein expression in abluminal sprouting and intraluminal splitting forms of angiogenesisClinical Science, 2006
- Capillary regression in vascular endothelial growth factor-deficient skeletal musclePhysiological Genomics, 2004
- VEGF signalling: integration and multi-tasking in endothelial cell biologyBiochemical Society Transactions, 2003
- Vascular endothelial growth factor: a new player in the pathogenesis of renal fibrosisCurrent Opinion in Nephrology and Hypertension, 2003
- Role of vascular endothelial growth factor in physiologic and pathologic angiogenesis: Therapeutic implicationsSeminars in Oncology, 2002
- Nitric Oxide Induces the Synthesis of Vascular Endothelial Growth Factor by Rat Vascular Smooth Muscle CellsArteriosclerosis, Thrombosis, and Vascular Biology, 2000
- Internal division of capillaries in rat skeletal muscle in response to chronic vasodilator treatment with α 1 -antagonist prazosinCell and tissue research, 1998
- Nitric oxide synthase lies downstream from vascular endothelial growth factor-induced but not basic fibroblast growth factor-induced angiogenesis.JCI Insight, 1997
- In VivoPericyte–Endothelial Cell Interaction during Angiogenesis in Adult Cardiac and Skeletal MuscleMicrovascular Research, 1996
- Competitive antagonism of nitric oxide synthetase causes weight loss in miceLife Sciences, 1992